Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500108157Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative pain comparing Group A: dezocine + sufentanil, Group B: flurbiprofen axetil + sufentanil and Group C: dezocine + flurbiprofen axetil + sufentanil (3 arms). Primary endpoint: VAS resting and activity pain scores. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500108157.